Venture Visionary Partners LLC lessened its holdings in shares of CME Group Inc. (NASDAQ:CME – Get Rating) by 5.1% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,939 shares of the financial services provider’s stock after selling 157 shares during the quarter. Venture Visionary Partners LLC’s holdings in CME Group were worth $563,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. Power Corp of Canada bought a new position in CME Group during the 1st quarter worth approximately $26,000. MayTech Global Investments LLC bought a new position in CME Group during the 4th quarter worth approximately $25,000. GW&K Investment Management LLC lifted its holdings in CME Group by 153.3% during the 4th quarter. GW&K Investment Management LLC now owns 152 shares of the financial services provider’s stock worth $26,000 after buying an additional 92 shares during the last quarter. CoreCap Advisors LLC bought a new position in CME Group during the 4th quarter worth approximately $26,000. Finally, Arlington Partners LLC bought a new position in CME Group during the 4th quarter worth approximately $27,000. Institutional investors and hedge funds own 85.98% of the company’s stock.
CME Group Stock Down 0.2 %
Shares of CME Group stock opened at $181.67 on Friday. The business’s fifty day moving average price is $183.58 and its two-hundred day moving average price is $181.56. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market capitalization of $65.35 billion, a P/E ratio of 23.08, a PEG ratio of 4.52 and a beta of 0.41. CME Group Inc. has a 1-year low of $166.54 and a 1-year high of $212.09.
CME Group Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 27th. Investors of record on Friday, June 9th will be issued a $1.10 dividend. This represents a $4.40 dividend on an annualized basis and a dividend yield of 2.42%. The ex-dividend date of this dividend is Thursday, June 8th. CME Group’s payout ratio is 55.91%.
Wall Street Analyst Weigh In
A number of research firms have commented on CME. JPMorgan Chase & Co. reduced their target price on CME Group from $196.00 to $194.00 and set a “neutral” rating on the stock in a report on Wednesday, April 19th. Rosenblatt Securities reissued a “sell” rating and issued a $161.00 price target on shares of CME Group in a report on Wednesday, April 5th. Deutsche Bank Aktiengesellschaft raised their price target on CME Group from $206.00 to $208.00 in a report on Thursday, April 27th. StockNews.com assumed coverage on CME Group in a report on Thursday, May 18th. They issued a “hold” rating on the stock. Finally, Morgan Stanley raised their price target on CME Group from $201.00 to $208.00 and gave the stock an “equal weight” rating in a report on Tuesday, April 11th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, CME Group currently has a consensus rating of “Hold” and a consensus price target of $210.50.
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
- Get a free research report on CME Group from StockNews.com
- MarketBeat Week in Review – 6/19 – 6/23
- CarMax Stock Flying On Earnings Beat, Return Of The Highs?
- Commercial Metals Company Shakes Off The Rust: Confirms Uptrend
- Smith & Wesson, A Timeless Value Play At Decade Lows
- Five stocks we like better than CME Group
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Get Rating).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
